iSpecimen/$ISPC
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About iSpecimen
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas, Europe, the Middle East, Africa, and the Asia Pacific, with the majority coming from the Americas. The Company has one reportable segment: biospecimens.
Ticker
$ISPC
Sector
Primary listing
Employees
7
Headquarters
Website
iSpecimen Metrics
BasicAdvanced
$3.9m
-
-$91.15
1.98
-
Price and volume
Market cap
$3.9m
Beta
1.98
52-week high
$5.75
52-week low
$4.00
Financial strength
Current ratio
1.116
Quick ratio
1.112
Long term debt to equity
6.861
Total debt to equity
8.704
Interest coverage (TTM)
-905.21%
Profitability
EBITDA (TTM)
-8.718
Gross margin (TTM)
1.25%
Net profit margin (TTM)
-543.68%
Operating margin (TTM)
-465.42%
Revenue per employee (TTM)
$280,000
Management effectiveness
Return on assets (TTM)
-59.44%
Return on equity (TTM)
-327.77%
Valuation
Price to revenue (TTM)
0.312
Price to book
0.36
Price to tangible book (TTM)
1.35
Price to free cash flow (TTM)
-0.115
Free cash flow yield (TTM)
-871.00%
Free cash flow per share (TTM)
-45.55
Growth
Revenue change (TTM)
-79.24%
Earnings per share change (TTM)
-87.04%
3-year revenue growth (CAGR)
-42.97%
3-year earnings per share growth (CAGR)
-53.86%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for iSpecimen stock?
iSpecimen (ISPC) has a market cap of $3.9M as of May 01, 2026.
What is the P/E ratio for iSpecimen stock?
The price to earnings (P/E) ratio for iSpecimen (ISPC) stock is 0 as of May 01, 2026.
Does iSpecimen stock pay dividends?
No, iSpecimen (ISPC) stock does not pay dividends to its shareholders as of May 01, 2026.
When is the next iSpecimen dividend payment date?
iSpecimen (ISPC) stock does not pay dividends to its shareholders.
What is the beta indicator for iSpecimen?
iSpecimen (ISPC) has a beta rating of 1.98. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.